Johannes E. Mann
Erlangen, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 154 publications
Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: June 05, 2026
Response to Comment on Rossing et al. Nuances in Interpretation: Assessing the Interaction Between Semaglutide and MRAs in the FLOW Trial.
Journal: Diabetes care
Published: May 20, 2026
Sexual Dimorphism and Age Effects in CKD and Type 2 Diabetes in the CONFIDENCE Trial.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: March 27, 2026
Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial.
Journal: JAMA cardiology
Published: March 25, 2026
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial.
Journal: Diabetes, obesity & metabolism
Published: February 23, 2026
Semaglutide and Cardiovascular Outcomes According to Baseline Aspirin Use: Analyses of the SOUL and SELECT Trials.
Journal: Diabetes, obesity & metabolism
Published: February 11, 2026
Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial.
Journal: JAMA internal medicine
Published: February 02, 2026
CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuum.
Journal: Cardiovascular diabetology
Published: January 26, 2026
Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis.
Journal: The lancet. Diabetes & endocrinology
Published: January 21, 2026
Safety of Semaglutide After Dialysis Initiation: An Individual-Level Pooled Analysis.
Journal: Diabetes care
Published: January 15, 2026
Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone.
Journal: Journal of the American Society of Nephrology : JASN
Published: January 14, 2026
Last Updated: 09/26/2026